Search results
Found 268 matches for
The results of a placebo-controlled randomised trial of remdesivir in COVID-19 patients have been published in the Lancet. Supported by the ISARIC Support Centre, scientists in China launched a trial of remdesivir in patients hospitalised with COVID-19. The results found no clinical benefit from use of the drug; however, while not statistically significant, the time to clinical improvement and duration of invasive mechanical ventilation were shorter in people treated with remdesivir.
KEMRI signs landmark partnership with Wellcome and Oxford
3 April 2025
The Kenya Medical Research Institute (KEMRI) has officially entered into a seven-year Memorandum of Understanding (MoU) with Wellcome, a UK-based charitable foundation, and the University of Oxford. The £91 million agreement was signed at the Wellcome headquarters in London, marking a significant boost for medical research and training in Kenya.
Lower-dose yellow fever vaccine as effective as the current standard
20 March 2025
In a recent study, researchers at the KEMRI Wellcome Trust Research Programme in Kenya have discovered that a low-dose of the yellow fever vaccine is as effective as the current standard dose.
Breaking Barriers: Dr Caroline Tigoi’s Journey in Science and Research
11 February 2025
The science field has largely been male-dominated from time immemorial and women in science are increasingly making their mark and breaking barriers through conducting and leading various ground-breaking research. The International Day of Women and Girls in Science is an annual observance in recognition of the critical role played by women and girls in science and the promotion of their full and equal access to participation in Science, Technology, Engineering and Mathematics fields. At KWTRP we celebrate, Dr Caroline Tigoi a dedicated scientist whose journey into microbiology and infectious disease research has not only advanced medical science but also inspired the next generation of women in STEM.
Launch of largest-ever study tracking chikungunya burden in East Africa
13 December 2024
A team of scientists in the UK, Kenya and Tanzania will soon find out the extent to which chikungunya, a debilitating mosquito-borne disease causing large outbreaks in Asia and South America, is also affecting countries in East Africa.
KEMRI renews collaboration with Oxford University and Wellcome Trust
29 November 2024
The Kenya Medical Research Institute (KEMRI) has signed a seven-year memorandum of agreement with the Wellcome Trust and the University of Oxford. Under this collaboration, Wellcome has awarded £91 million (KES 15 billion) to support research over the next seven years. KEMRI have been collaborating with the Wellcome Trust and the University of Oxford on improving health through research for over 35 years.
Rift Valley fever vaccine to enter Phase II clinical trials in Kenya
14 October 2024
A promising human vaccine candidate against the potentially deadly Rift Valley fever, a mosquito-borne disease affecting countries across Africa, is set to begin Phase II trials in Kenya. This is the most advanced stage of testing a human Rift Valley fever vaccine has reached in an outbreak-prone area to date. A team of scientists at the Nuffield Department of Medicine and the KEMRI-Wellcome Trust Research Programme will lead the $3.7m trial, funded by the Coalition for Epidemic Preparedness Innovations (CEPI).
Improving survival rates of children with sickle cell disease in Kenya
19 September 2024
Research on sickle cell disease conducted by KEMRI-Wellcome Trust Research Programme (KWTRP) at the Nuffield Department of Medicine shows significant progress in understanding how to improve survival rates and quality of life for those living with the condition.
Hydroxychloroquine provides moderate COVID-19 prevention, large clinical trial shows
12 September 2024
Four years after being derailed by scientific fraud and politicised science in the first year of the pandemic, COPCOV, the world’s largest COVID-19 chemoprevention study, finally published results today that showed that hydroxychloroquine (HCQ) does have a moderate benefit in preventing COVID-19.
KWTRP exhibits at the Kenya National Research Festival 2024
12 September 2024
KEMRI-Wellcome Trust Research Programme (KWTRP) hosted an exhibition as part of the British High Commission Pavilion during the Kenya National Research Festival 2024. Under the theme “Research Partnerships and collaborations for Socio-Economic Transformation” the festival aimed to raise awareness about the diverse spectrum of research activities in Kenya and internationally encouraging collaboration.
Seven CTMGH researchers awarded full professorships
3 September 2024
We are delighted to announce that seven of our researchers have been awarded the title of Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
Visit MalariaWorld
24 July 2024
The Malariaworld exhibition was developed in conjunction with World Malaria Day 2024 to raise awareness of malaria and malaria research, and to highlight some of our contributions to malaria research. You can now visit our virtual exhibition!
KWTRP Annual Policy Engagement Forum
20 June 2024
The KEMRI Wellcome Trust Research Programme (KWTRP) hosted its annual policy engagement forum in Nairobi. This year’s forum provided a valuable platform for deliberation between policy stakeholders and researchers, focusing on their research needs and policy priorities. The event is part of a larger consultative process towards the development of the KWTRP strategic plan.
Associate Professors 2024
17 May 2024
We are pleased to announce that six of our researchers have been awarded the title Associate Professor
Improving pneumonia recovery in malnourished African children
17 May 2024
A project by the KEMRI Wellcome Trust Research Programme (KWTRP) at NDM highlighted the importance of future trials focussing on high-risk, undernourished children and using feeds tailored to their metabolic needs.
The KEMIS Project at KWTRP
15 May 2024
Serosurveillance remains a valuable yet underutilized tool. Through the KEMIS project, KWTRP aim to demonstrate the value of multi-pathogen serosurveillance in Kenya.
Celebrating World Malaria Day 2024
25 April 2024
On this World Malaria Day 2024, Professor Marta Maia from the KEMRI Welcome Trust Research Programme in Kilifi, Kenya, talks about her research work and shares her reflections on climate change and what this means to vector biology and current interventions.
Visit our exhibition: Malariaworld
17 April 2024
The Malariaworld exhibition has been developed for World Malaria Day 2024 to raise awareness of malaria and malaria research. We highlight some of the Nuffield Department of Medicine’s contributions to malaria research. Come and visit our exhibition at the John Radcliffe Academic Centre, 22-29 April 2024.
NEWRISK project awarded RIGHT 5 NHIR funding
27 February 2024
Led by Benjamin Tsofa and Jacob McKnight, the project named "A Novel Extreme Weather Risk Insurance System for Kenya (NEWRISK)” will focus on using the latest methods to provide focused data on extreme weather, population vulnerability, and health system capacity readiness across various climatic zones in Kenya.
School Leavers Attachment Scheme
22 February 2024
KWTRP hosted 153 students for the Annual School Leavers Attachment Scheme (SLAS) Open Day. The SLAS open day targets top performing students in Kilifi to give them an opportunity to information from various stakeholders and scientists that would help them firm up or redefine their career aspirations. It is an opportunity to give the students information about the need to take science and health related careers with the focus on creating the next pool of researchers in Kenya, Africa and beyond.
12 Remarkable African Life Scientists– An inspirational book for young people
18 February 2024
Dr Tabitha Mwangi, a former KWTRP scientist now working in the UK, has written an inspirational book targeted at High school going children but also useful in shaping students already in university in shaping their career journeys.